* By Ramesh Govindaraj, Michael R. Reich, and Karin Dumbaugh.
This chapter provides a description of the supply of
praziquantel since its introduction in the international market in the late
1970s. It first presents basic data on producers and formulators of
praziquantel, including firms that manufacture the drugs active
ingredients and firms that only formulate tablets from purchased raw materials.
The chapter next describes the global distribution of praziquantel, with
particular attention to the role of bulk suppliers in developing country